Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Sierra Leone
Sierra Leone: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage was 93.0% in 2024. ▲ Rising
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Sierra Leone, 2011–2024
Source: WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data. Measured in %.
Analysis
The most recent figure for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Sierra Leone is 93.0%, measured in 2024.
The figure is up 12.0% over ten years.
Over the whole period, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Sierra Leone peaked at 94.0% in 2019 and was at its lowest, 75.0%, in 2011.
That places Sierra Leone 43rd out of 146 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 14 years of available data.
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Sierra Leone, year by year
| Year | % | Change |
|---|---|---|
| 2011 | 75.0% | — |
| 2012 | 92.0% | +22.7% |
| 2013 | 92.0% | +0.0% |
| 2014 | 83.0% | -9.8% |
| 2015 | 86.0% | +3.6% |
| 2016 | 84.0% | -2.3% |
| 2017 | 90.0% | +7.1% |
| 2018 | 92.0% | +2.2% |
| 2019 | 94.0% | +2.2% |
| 2020 | 91.0% | -3.2% |
| 2021 | 90.0% | -1.1% |
| 2022 | 93.0% | +3.3% |
| 2023 | 93.0% | +0.0% |
| 2024 | 93.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 87.6% | 75.0% | 94.0% | 9 |
| 2020s | 92.0% | 90.0% | 93.0% | 5 |
Countries ranked near Sierra Leone
More health data for Sierra Leone
- Un projection of annual infant deaths, annual growth rate -2.34 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.773 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,199 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4,209 deaths (2100)
- Population ages 0-14, female, annual growth rate 0.8723 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0.0002 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.1868 units per person (2025)
- Population ages 0-14, male, annual growth rate 0.8951 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0.0002 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.1897 units per person (2025)
Frequently asked questions
- What is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Sierra Leone?
- Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Sierra Leone was 93.0% in 2024, according to WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data.
- What is the highest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Sierra Leone?
- The highest recorded value was 94.0% in 2019.
- What is the lowest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Sierra Leone?
- The lowest recorded value was 75.0% in 2011.
- How does Sierra Leone rank for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Sierra Leone ranks 43rd out of 146 countries with data for 2024.
- Is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage rising or falling in Sierra Leone?
- Over the last ten years it is up 12.0%. The long-run trend across the full record is rising.
- Where does this Sierra Leone data come from?
- The figures come from WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as part of Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 14 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.